NUTRISANTE   Report issue

For profit Phase 3
Founded: MONTAIGU France (1992)
Status: No NME R&D (1992)

Organization Overview

First Clinical Trial
2012
NCT01708005
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 3 Trials (1)

vitamin d3 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cognitive Dysfunction (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 1